Literature DB >> 18220784

Molecular dynamics simulations of metalloproteinases types 2 and 3 reveal differences in the dynamic behavior of the S1' binding pocket.

Cesar Augusto F de Oliveira1, Maurice Zissen, John Mongon, J Andrew McCammon.   

Abstract

Matrix Metalloproteinases (MMPs) are zinc-containing proteinases that are responsible for the metabolism of extracellular matrix proteins. Overexpression of MMPs has been associated with a wide range of pathological diseases such as arthritis, cancer, multiple sclerosis and Alzheimer's disease. The excessive and unregulated activity of Matrix Metalloproteinases type 2 (MMP-2), also known as gelatinase A, has been identified in a numbers of cancer metastases. Several MMP inhibitors (MMPi) have been proposed in the literature aiming to interfere in the MMPs activity. In this work we performed long MD simulations in order to study the dynamical behavior of the binding pocket S1' in the apo forms of MMP type 2 and 3, and identify, at the molecular level, the structural properties relevant for the designing of specific inhibitor of MMP-2.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18220784     DOI: 10.2174/138161207782794211

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  6 in total

1.  Pyrone-based inhibitors of metalloproteinase types 2 and 3 may work as conformation-selective inhibitors.

Authors:  Jacob D Durrant; César A F de Oliveira; J Andrew McCammon
Journal:  Chem Biol Drug Des       Date:  2011-06-20       Impact factor: 2.817

2.  Characterization and regulation of MT1-MMP cell surface-associated activity.

Authors:  Sonia Pahwa; Manishabrata Bhowmick; Sabrina Amar; Jian Cao; Alex Y Strongin; Rafael Fridman; Stephen J Weiss; Gregg B Fields
Journal:  Chem Biol Drug Des       Date:  2018-12-19       Impact factor: 2.817

3.  POVME: an algorithm for measuring binding-pocket volumes.

Authors:  Jacob D Durrant; César Augusto F de Oliveira; J Andrew McCammon
Journal:  J Mol Graph Model       Date:  2010-11-03       Impact factor: 2.518

4.  An integrated computational approach to rationalize the activity of non-zinc-binding MMP-2 inhibitors.

Authors:  Antonella Di Pizio; Mariangela Agamennone; Massimiliano Aschi
Journal:  PLoS One       Date:  2012-11-08       Impact factor: 3.240

5.  Including receptor flexibility and induced fit effects into the design of MMP-2 inhibitors.

Authors:  Jacob D Durrant; César Augusto F de Oliveira; J Andrew McCammon
Journal:  J Mol Recognit       Date:  2010 Mar-Apr       Impact factor: 2.137

6.  Structural Variations of Human Glucokinase Glu256Lys in MODY2 Condition Using Molecular Dynamics Study.

Authors:  Nanda Kumar Yellapu; Kalpana Kandlapalli; Koteswara Rao Valasani; P V G K Sarma; Bhaskar Matcha
Journal:  Biotechnol Res Int       Date:  2013-02-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.